EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Novel insights into macrophage immunometabolism in nonalcoholic steatohepatitis

Yali Yuan, Ye Zhang, Xinyu Lu, Junxiang Li, Muyuan Wang, Wenji Zhang, Mengyu Zheng, Zhongmei Sun, Yunqi Xing, Yitong Li, Yingdi Qu, Yao Jiao und 3 weitere

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.111833 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Yali Yuan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, PR China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 112 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonalcoholic steatohepatitis (NASH), an inflammatory subtype of nonalcoholic fatty liver disease (NAFLD), is characterized by liver steatosis, inflammation, hepatocellular injury and different degrees of fibrosis, and has been becoming the leading cause of liver-related morbidity and mortality worldwide. Unfortunately, the pathogenesis of NASH has not been completely clarified, and there are no approved therapeutic drugs. Recent accumulated evidences have revealed the involvement of macrophage in the regulation of host liver steatosis, inflammation and fibrosis, and different phenotypes of macrophages have different metabolic characteristics. Therefore, targeted regulation of macrophage immunometabolism may contribute to the treatment and prognosis of NASH. In this review, we summarized the current evidences of the role of macrophage immunometabolism in NASH, especially focused on the related function conversion, as well as the strategies to promote its polarization balance in the liver, and hold promise for macrophage immunometabolism-targeted therapies in the treatment of NASH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseHumansLiverInflammationFibrosisMacrophages

Stichwörter der Autor:innen

ImmunometabolismMacrophageMetabolic characteristicsNonalcoholic steatohepatitisStrategies

Autor:innen und Institutionen

  • Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, PR China.
  • King's College, London, UK.
  • Tianjin Nankai Hospital, Tianjin, PR China.
  • Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, PR China. Electronic address: hujiaofen@163.com.
  • Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, PR China; Shenzhen Bao'an Traditional Chinese Medicine Hospital, Shenzhen, PR China. Electronic address: xiechune@sina.com.
  • Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, PR China. Electronic address: maotangyouqun@126.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yuan, Y., Zhang, Y., Lu, X., Li, J., Wang, M., Zhang, W., Zheng, M., Sun, Z., Xing, Y., Li, Y., Qu, Y., Jiao, Y., Han, H., Xie, C., & Mao, T. (2024). Novel insights into macrophage immunometabolism in nonalcoholic steatohepatitis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.111833

Vancouver

Yuan Y, Zhang Y, Lu X, Li J, Wang M, Zhang W, et al. Novel insights into macrophage immunometabolism in nonalcoholic steatohepatitis. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.111833

BibTeX
@article{Yuan2024,
  author = {Yuan, Yali and Zhang, Ye and Lu, Xinyu and Li, Junxiang and Wang, Muyuan and Zhang, Wenji and Zheng, Mengyu and Sun, Zhongmei and Xing, Yunqi and Li, Yitong and Qu, Yingdi and Jiao, Yao and Han, Haixiao and Xie, Chune and Mao, Tangyou},
  title = {Novel insights into macrophage immunometabolism in nonalcoholic steatohepatitis},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.111833}
}
Kostenlos starten →